Categories Earnings Calls, Health Care

Biogen, Inc. (BIIB) Q4 2020 Earnings Call

Biogen, Inc. (NASDAQ: BIIB) Q4 2020 earnings call dated Feb. 03, 2021

Corporate Participants:

Mike Hencke — Director, Investor Relations

Michel Vounatsos — Chief Executive Officer

Alfred W. Sandrock — Executive Vice President

Michael McDonnell — Executive Vice President Chief Financial Officer


Max Skor — Morgan Stanley — Analyst

Terence Flynn — Goldman Sachs — Analyst

Marc Goodman — SVB Leerink — Analyst

Umer Raffat — Evercore — Analyst

Cory Kasimov — JPMorgan — Analyst

Evan Seigerman — Credit Suisse — Analyst

Michael Yee — Jefferies — Analyst

Paul Matteis — Stifel — Analyst

Phil Nadeau — Cowen & Company — Analyst

Jay Olson — Oppenheimer — Analyst

Robyn Karnauskas — Truist — Analyst

Salim Syed — Mizuho — Analyst

To read the full earnings call transcript, click here

Most Popular

ACN Earnings: All you need to know about Accenture’s Q2 2023 earnings results

Accenture (NYSE: ACN) reported second quarter 2023 earnings results today. Total revenues increased 5% year-over-year to $15.8 billion. Net income attributable to Accenture plc was $1.52 billion, or $2.39 per

Here’s how FedEx (FDX) plans to soften the impact of volume declines on its business

Shares of FedEx Corporation (NYSE: FDX) stayed green on Wednesday. The stock has gained 26% year-to-date. The company faced a challenging environment in the third quarter of 2023 which took

Walgreens Boots Alliance (WBA) shifts to expansion mode. Will it pay off?

Walgreens Boots Alliance, Inc. (NASDAQ: WBA), a market leader in retail pharmacy, has regularly revised its business model to better align with the transformation the healthcare space is witnessing. Currently,

Add Comment
Viewing Highlight